Ivarmacitinib's oral administration and rapid onset make it a promising systemic therapy, comparable to abrocitinib and upadacitinib. Further research is needed to confirm long-term safety and ...

Credit: Eton. Khindivi is expected to be available the week of June 2, 2025. Khindivi is the first FDA-approved hydrocortisone oral solution. The Food and Drug Administration (FDA) has approved ...

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml strength designed to eliminate the need to split or crush tablets, and to offer simple and accurate ...

Credit: Caleb Woods on Unsplash. Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a ...

. Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, I ...

KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml strength designed to eliminate the need to split or crush tablets, and to offer simple and ...

Briana Bierschbach is a politics and government reporter for the Star Tribune. Dee DePass is an award-winning business reporter covering Minnesota small businesses for the Minnesota Star Tribune ...

Colgate-Palmolive India MD and CEO Prabha Narasimhan said over two-thirds of urban consumers are under financial stress, leading to lower demand for oral care and other FMCG products. Only 30% of ...

These lipophilic compounds often exhibit poor systemic exposure following oral administration ... formulations for which components are 'all in' solution or 'all out' (that is, solid) simplify ...